Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Feb 14 2002
Washington, D.C. (February 14, 2002) - The Biotechnology Industry Organization (BIO) today announced the names of industry leaders who will participate in the...
Feb 13 2002
Washington, D.C. (February 13, 2002) – The Biotechnology Industry Organization (BIO) today announced that Dr. Harold Varmus, recipient of the Nobel Prize...
Feb 12 2002
Washington, D.C. (February 12, 2002) - Christopher Reeve, the actor, director and patients’ rights advocate, will participate in a panel discussion on...
Feb 8 2002
WASHINGTON, D.C. – (February 8, 2002) – Biotechnology Industry Organization President Carl B. Feldbaum described the $272 million in user fees...
Feb 5 2002
Washington, D.C. (February 5, 2002)- The Biotechnology Industry Organization (BIO) today announced the names of the biotechnology companies selected to present...
Feb 4 2002
Washington, D.C. (February 4, 2002) – The FDA approved 16 new biotechnology-based medicines and vaccines in 2001, as well as eight new indications for...
Jan 30 2002
WASHINGTON, DC – (January 30, 2002) – Advance media registration for the 16th annual BIO 2002 International Convention and Exhibition is now available. The...
Jan 18 2002
WASHINGTON, D.C. - (January 18, 2002) - Biotechnology Industry Organization Vice President for Bioethics Michael Werner released the following statement on the...
Dec 19 2001
Washington, D.C. (December 19, 2001) – The Centers for Medicare and Medicaid Services Wednesday postponed by at least three months implementation of a...


Biotechnology News

August 30, 2014

PRINCETON, N.J. & NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) today announced results of a pre-specified secondary...

August 29, 2014

ELYRIA, Ohio--(BUSINESS WIRE)--Invacare (NYSE: IVC) announces sale of Altimate Medical to Rockwood Equity Partners for approximately $23,000,000 in cash, subject to an...

August 29, 2014

BOSTON--(BUSINESS WIRE)--Boston Strategics has begun a Phase 1 clinical trial of FUJIFILM’s anti-cancer agent FF-10501 in patients with advanced hematologic malignancies...

August 29, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--Smiths Medical, a leading global medical device manufacturer, announced today that it is initiating a nationwide recall of certain lots...

August 29, 2014

SARASOTA, Fla.--(BUSINESS WIRE)--BioFlorida's Sarasota-Bradenton Chapter debuts the first BioTech Expo in the region to include a combination Life Science Poster &...